Trail Biomed is awarded a grant of over $2.65million from the Gates Foundation. Trail Biomed, a Swiss company founded by AmalioTelenti, aims at advancing global health through innovative therapeutics. This funding will support the development of a working framework for data interoperability and validation, integrating wet bench data generation with AI tools to create novel, cost-effective small molecule therapies to improve public health.This initiative represents a significant step toward addressing critical gaps in data integration and fostering rapid testing and validation of drug leads. For more information, visit trail biomed.